Ac-LEHD-AMC

What We Offer

Ac-LEHD-AMC

Ac-LEHD-AMC | CAS 292633-16-0

Catalog Number A18-0023
Category Fluorescent Enzyme Substrates
Molecular Formula C33H41N7O11
Molecular Weight 711.7
Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Introduction

Ac-LEHD-AMC is a fluorogenic substrate for caspase-9. Ac-LEHD-AMC is cleaved by caspase-9 to release the fluorescent moiety AMC, which can be used to quantify caspase-9 activity.

  • Chemical Information

  • Product Specification

  • Application

  • Computed Properties

  • Patents

Synonyms N-acetyl-L-leucyl-L-α-glutamyl-L-histidyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-α-asparagine
Purity ≥95%
IUPAC Name (4S)-4-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S)-3-carboxy-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Canonical SMILES CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C
InChI InChI=1S/C33H41N7O11.C2HF3O2/c1-16(2)9-23(36-18(4)41)32(49)38-22(7-8-27(42)43)30(47)39-24(11-20-14-34-15-35-20)33(50)40-25(13-28(44)45)31(48)37-19-5-6-21-17(3)10-29(46)51-26(21)12-19;3-2(4,5)1(6)7/h5-6,10,12,14-16,22-25H,7-9,11,13H2,1-4H3,(H,34,35)(H,36,41)(H,37,48)(H,38,49)(H,39,47)(H,40,50)(H,42,43)(H,44,45);(H,6,7)/t22-,23-,24-,25-;/m0./s1
InChIKey UOZNIAKIZDCQSH-NATPOTRJSA-N
Storage Store at -20°C
XLogP3 -0.3
Hydrogen Bond Donor Count 8
Hydrogen Bond Acceptor Count 12
Rotatable Bond Count 18
Exact Mass 711.28640515 g/mol
Monoisotopic Mass 711.28640515 g/mol
Topological Polar Surface Area 275Ų
Heavy Atom Count 51
Formal Charge 0
Complexity 1370
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes
Publication Number Title Priority Date
EP-3929209-A1 Vasopressin-2 receptor antagonist peptides and uses thereof 2020-06-24
WO-2019227240-A1 Methods for treating cancer with acyldepsipeptide analogs 2018-06-01
CA-3102215-A1 Methods for treating cancer with acyldepsipeptide analogs 2018-06-01
US-2021122780-A1 Compositions for the prevention and treatment of parkinson's disease 2018-03-29
US-2022267367-A1 Compositions for the prevention and treatment of parkinson's disease 2018-03-29

Recommended Services

Recommended Articles

Recommended Products

Online Inquiry

Verification code
cartIcon
Inquiry Basket